Indicators Affecting PVT Recanalization

Recruiting now

Conditions studied: Portal Vein Thrombosis, Cirrhosis, Portal Hypertension Related to Cirrhosis, Portal Hypertension, Noncirrhotic

In brief

This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.

Key facts

Study ID

NCT07473375

Run by

Shanghai Zhongshan Hospital

People needed

1500

Starts

2017-01-01

Expected to finish

2028-12-31

Last updated by the study team

2026-03-16

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
• all patients were diagnosed as PVT by CTA at admission.

You may not qualify if…

• patients with hepatocellular carcinoma;
• patients with extrahepatic malignancies;
• history of liver transplantation or TIPS;
• lack of information regarding anticoagulation therapy；
• those with cavernous transformation of the portal vein(CTPV) .

Where it is running

• Study site — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.